{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:05:25Z","timestamp":1792209925408,"version":"4.4.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Advances"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jacadv.2025.102204","type":"journal-article","created":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:14:56Z","timestamp":1759554896000},"page":"102204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P1","title":["Patient-Reported Outcomes in Older Adults With Transthyretin Amyloid Cardiomyopathy"],"prefix":"10.1016","volume":"4","author":[{"given":"Tessa","family":"Zeis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.H.Wilson","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7474-3737","authenticated-orcid":false,"given":"Parag","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazen","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulla","family":"Damluji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trejeeve","family":"Martyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jacadv.2025.102204_bib1","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1001\/jamacardio.2021.0372","article-title":"Comparison of New York heart association class and patient-reported outcomes for heart failure with reduced ejection fraction","volume":"6","author":"Greene","year":"2021","journal-title":"JAMA Cardiol"},{"issue":"5","key":"10.1016\/j.jacadv.2025.102204_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.14797\/mdcvj.1163","article-title":"Opportunities for earlier diagnosis and treatment of cardiac amyloidosis","volume":"18","author":"Martyn","year":"2022","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"10.1016\/j.jacadv.2025.102204_bib3","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/eurjhf\/hft071","article-title":"Preferences of heart failure patients in daily clinical practice: quality of life or longevity?","volume":"15","author":"Kraai","year":"2013","journal-title":"Eur J Heart Fail"},{"issue":"36","key":"10.1016\/j.jacadv.2025.102204_bib4","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1093\/eurheartj\/ehad514","article-title":"Placing patient-reported outcomes at the centre of cardiovascular clinical practice: implications for quality of care and management","volume":"44","author":"Moons","year":"2023","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.jacadv.2025.102204_bib5","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1007\/s11136-024-03723-y","article-title":"Health-related quality of life is an independent predictor of mortality and hospitalisations in transthyretin amyloid cardiomyopathy: a prospective cohort study","volume":"33","author":"Poledniczek","year":"2024","journal-title":"Qual Life Res"},{"issue":"15","key":"10.1016\/j.jacadv.2025.102204_bib6","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1161\/CIRCULATIONAHA.124.072158","article-title":"Patient-reported outcomes as end points in heart failure trials","volume":"151","author":"Butler","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.jacadv.2025.102204_bib7","doi-asserted-by":"crossref","first-page":"zwad400","DOI":"10.1093\/eurjpc\/zwad400","article-title":"Quality of life in heart failure. The heart of the matter. A scientific statement of the heart failure association and the European association of preventive cardiology of the European society of cardiology","volume":"32","author":"Volterrani","year":"2025","journal-title":"Eur J Prev Cardiol"},{"issue":"20","key":"10.1016\/j.jacadv.2025.102204_bib8","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1056\/NEJMoa2300525","article-title":"Transcatheter repair for patients with tricuspid regurgitation","volume":"388","author":"Sorajja","year":"2023","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jacadv.2025.102204_bib9","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1056\/NEJMoa2305434","article-title":"Efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathy","volume":"390","author":"Gillmore","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacadv.2025.102204_bib10","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.amjcard.2020.10.066","article-title":"Impact of tafamidis on health-related quality of life in patients with transthyretin amyloid cardiomyopathy (from the tafamidis in transthyretin cardiomyopathy clinical trial)","volume":"141","author":"Hanna","year":"2021","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.jacadv.2025.102204_bib11","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/ejhf.3190","article-title":"Effect of long-term tafamidis treatment on health-related quality of life in patients with transthyretin amyloid cardiomyopathy","volume":"26","author":"Grogan","year":"2024","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.jacadv.2025.102204_bib12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa2409134","article-title":"Vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy","volume":"392","author":"Fontana","year":"2025","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jacadv.2025.102204_bib13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10741-024-10444-4","article-title":"Contextualizing the results of HELIOS-B in the broader landscape of clinical trials for the treatment of transthyretin cardiac amyloidosis","volume":"30","author":"Girard","year":"2025","journal-title":"Heart Fail Rev"},{"issue":"3","key":"10.1016\/j.jacadv.2025.102204_bib14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jchf.2015.10.015","article-title":"Utility of patient-reported outcome instruments in heart failure","volume":"4","author":"Kelkar","year":"2016","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacadv.2025.102204_bib15","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/jns5.12059","article-title":"Norfolk QOL-DN: validation of a patient reported outcome measure in transthyretin familial amyloid polyneuropathy","volume":"19","author":"Vinik","year":"2014","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.jacadv.2025.102204_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1124660","article-title":"Amylo-AFFECT-QOL, a self-reported questionnaire to assess health-related quality of life and to determine the prognosis in cardiac amyloidosis","volume":"10","author":"Kharoubi","year":"2023","journal-title":"Front Cardiovasc Med"},{"issue":"9","key":"10.1016\/j.jacadv.2025.102204_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.101123","article-title":"Comprehensive geriatric assessment to optimize the management of older patients with transthyretin cardiac amyloidosis","volume":"3","author":"Fumagalli","year":"2024","journal-title":"JACC Adv"},{"issue":"1","key":"10.1016\/j.jacadv.2025.102204_bib18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s41687-025-00880-7","article-title":"Reliability and validity of the transthyretin amyloidosis - quality of life (ATTR-QOL) questionnaire impact scales","volume":"9","author":"Lovley","year":"2025","journal-title":"J Patient Rep Outcomes"},{"issue":"1","key":"10.1016\/j.jacadv.2025.102204_bib19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/13506129.2023.2254451","article-title":"Patient-reported outcome measures for transthyretin cardiac amyloidosis: the Italy study","volume":"31","author":"Aimo","year":"2024","journal-title":"Amyloid"}],"container-title":["JACC: Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X25006313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X25006313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T18:27:32Z","timestamp":1775068052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772963X25006313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2772963X25006313"],"URL":"https:\/\/doi.org\/10.1016\/j.jacadv.2025.102204","relation":{},"ISSN":["2772-963X"],"issn-type":[{"value":"2772-963X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient-Reported Outcomes in Older Adults With Transthyretin Amyloid Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"JACC: Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacadv.2025.102204","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"102204"}}